175 related articles for article (PubMed ID: 794955)
1. Search for correlations between immunological and morphological criteria used to classify lymphoid leukemias and non-Hodgkin's hematosarcomas with special reference to scanning electron microscopy and T and B membrane markers.
Belpomme D; Dantchev D; Karima AM; Lelarge N; Joseph R; Caillou B; Lafleur M; Mathé G
Recent Results Cancer Res; 1976; (56):131-43. PubMed ID: 794955
[No Abstract] [Full Text] [Related]
2. Progress in the classification of lymphoid and/or monocytoid leukemias and of lympho and reticulosarcomas (non-Hodgkin's lymphomas).
Mathé G; Belpomme D; Dantchev D; Pouillart P
Biomedicine; 1975 May; 22(3):177-85. PubMed ID: 809067
[TBL] [Abstract][Full Text] [Related]
3. An immunological classification of leukemias and non Hodgkin's hematosarcomas based on T and B cell membrane markers with special reference to null "cell" disorders.
Belpomme D; Lelarge N; Joseph R; Mathe G
Eur J Cancer (1965); 1977; 13(4-5):311-9. PubMed ID: 326549
[No Abstract] [Full Text] [Related]
4. Categorization of non-Hodgkin's hematosarcomas (lymphomas) according to T- and B-cell markers: its value for diagnosis and prognosis.
Belpomme D; Caillou B; Lelarge N; Botto I; Pujade Lauraine E; Denaro L; Gerard-Marchant R; Davies AJ; Mathé G
Recent Results Cancer Res; 1978; 64():146-57. PubMed ID: 366693
[No Abstract] [Full Text] [Related]
5. An immunological classification of leukemias and hematosarcomas based on cell membrane markers with special reference to null cell disorders.
Belpomme D; Lelarge N; Feuilhade de Chauvin F; Joseph R; Mathé G
Recent Results Cancer Res; 1976; (56):98-110. PubMed ID: 1087447
[No Abstract] [Full Text] [Related]
6. Immunologic classification of leukemia and lymphoma.
Foon KA; Todd RF
Blood; 1986 Jul; 68(1):1-31. PubMed ID: 2941082
[TBL] [Abstract][Full Text] [Related]
7. Surface markers define human lymphoid malignancies with differing prognoses.
Kersey J; Coccia P; Bloomfield C; Nesbit M; McKenna R; Brunning R; Hallgren H; Gajl-Peczalska K
Haematol Blood Transfus; 1977; 20():17-24. PubMed ID: 305392
[No Abstract] [Full Text] [Related]
8. T and B lymphocytic nature of leukemias and lymphosarcomas: a new but still uncertain parameter for their classification.
Mathé G; Belpomme D
Biomedicine; 1974 Mar; 20(2):81-5. PubMed ID: 4546936
[No Abstract] [Full Text] [Related]
9. Immunologic approach to non-Hodgkin lymphomas and related leukemias. Analysis of the results of multiparameter studies of 425 cases.
Lukes RJ; Parker JW; Taylor CR; Tindle BH; Cramer AD; Lincoln TL
Semin Hematol; 1978 Oct; 15(4):322-51. PubMed ID: 366759
[No Abstract] [Full Text] [Related]
10. [Recent progress made in the classification of lymphoid and monocytoid leukemias and of lympho- and reticulo-sarcomas].
Mathe G; Belpomme D; Dantchev D; Pouillart P
Ann Med Interne (Paris); 1975; 126(8-9):523-34. PubMed ID: 766687
[TBL] [Abstract][Full Text] [Related]
11. Immunologic classification of non-Hodgkin's lymphomas: current status.
Seligmann M; Brouet JC; Preud'homme JL
Cancer Treat Rep; 1977 Sep; 61(6):1179-83. PubMed ID: 332351
[No Abstract] [Full Text] [Related]
12. Etiological, clinical and prognostic significance of the T-B immunological classification of primary acute lymphoid leukemias and non Hodgkin's lymphomas.
Belpomme D; Lelarge N; Mathé G; Davies AJ
Haematol Blood Transfus; 1977; 20():33-45. PubMed ID: 305400
[TBL] [Abstract][Full Text] [Related]
13. Detection of intracellular and cell surface immunoglobulin in non-Hodgkin's lymphoma.
Davey FR; Halliday D; Marucci AA; Gottlieb AJ
Hum Pathol; 1978 May; 9(3):285-94. PubMed ID: 350755
[No Abstract] [Full Text] [Related]
14. [A new physio-morphological approach to malignant non hodgkinian lymphomas].
Cabanne PF
Bull Cancer; 1974; 61(1):1-9. PubMed ID: 4617605
[No Abstract] [Full Text] [Related]
15. Immunologic definition of lymphocytes: functions and markers.
Stathopoulos G; Davies AJ
Recent Results Cancer Res; 1976; (56):17-23. PubMed ID: 1087443
[No Abstract] [Full Text] [Related]
16. Evaluation of T and B lymphocyte membrane markers in human non-Hodgkin malignant lymphomata.
Brouet JC; Labaume S; Seligmann M
Br J Cancer Suppl; 1975 Mar; 2():121-7. PubMed ID: 1081001
[TBL] [Abstract][Full Text] [Related]
17. Immunological characterization of lymphoproliferative disorders by membrane markers.
Huber H; Michlmayr G; Huber C; Falkensammer M
Klin Wochenschr; 1976 Aug; 54(15):699-708. PubMed ID: 790006
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the blast cell in childhood non-Hodgkin's lymphoproliferative malignancies.
Coccia PF
Semin Oncol; 1977 Sep; 4(3):287-96. PubMed ID: 335518
[No Abstract] [Full Text] [Related]
19. Immunologic abnormalities in patients with malignant lymphoproliferative diseases.
Hunter CP; Tannenbaum H; Churchill WH; Moloney WC; Schur PH
J Natl Cancer Inst; 1977 May; 58(5):1185-90. PubMed ID: 323504
[TBL] [Abstract][Full Text] [Related]
20. [Morphologic classifications of lymphoid hematosarcomas].
Diebold J
Bull Cancer; 1974; 61(1):37-8. PubMed ID: 4617609
[No Abstract] [Full Text] [Related]
[Next] [New Search]
